FRAU, DANIELA VIRGINIA
 Distribuzione geografica
Continente #
EU - Europa 137.517
NA - Nord America 4.297
AS - Asia 1.809
SA - Sud America 266
AF - Africa 26
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 6
Totale 143.928
Nazione #
IT - Italia 136.201
US - Stati Uniti d'America 4.220
CN - Cina 838
SG - Singapore 706
UA - Ucraina 379
SE - Svezia 333
BR - Brasile 221
DE - Germania 197
FI - Finlandia 130
GB - Regno Unito 116
VN - Vietnam 92
CA - Canada 57
FR - Francia 42
KR - Corea 39
IN - India 23
AR - Argentina 21
JP - Giappone 21
BE - Belgio 18
ES - Italia 17
HK - Hong Kong 17
NL - Olanda 16
BD - Bangladesh 14
AT - Austria 13
MX - Messico 13
PL - Polonia 12
RU - Federazione Russa 11
EC - Ecuador 9
ZA - Sudafrica 9
ID - Indonesia 8
JO - Giordania 8
LT - Lituania 7
EU - Europa 6
IQ - Iraq 6
TR - Turchia 6
IE - Irlanda 5
CO - Colombia 4
CZ - Repubblica Ceca 4
HU - Ungheria 4
IR - Iran 4
NZ - Nuova Zelanda 4
PK - Pakistan 4
PY - Paraguay 4
SN - Senegal 4
AU - Australia 3
AZ - Azerbaigian 3
CL - Cile 3
EG - Egitto 3
KG - Kirghizistan 3
NP - Nepal 3
PT - Portogallo 3
SA - Arabia Saudita 3
CH - Svizzera 2
MA - Marocco 2
NO - Norvegia 2
PA - Panama 2
TH - Thailandia 2
TN - Tunisia 2
VE - Venezuela 2
AL - Albania 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BJ - Benin 1
BO - Bolivia 1
CG - Congo 1
CY - Cipro 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GI - Gibilterra 1
HN - Honduras 1
IL - Israele 1
IS - Islanda 1
JM - Giamaica 1
KE - Kenya 1
KW - Kuwait 1
KZ - Kazakistan 1
LB - Libano 1
MY - Malesia 1
NG - Nigeria 1
PE - Perù 1
PH - Filippine 1
PR - Porto Rico 1
QA - Qatar 1
RO - Romania 1
UZ - Uzbekistan 1
Totale 143.928
Città #
Cagliari 133.508
Uta 2.304
Ashburn 407
Chandler 373
Singapore 334
Fairfield 272
Woodbridge 265
Ann Arbor 248
Dallas 232
Nyköping 229
Boardman 206
Jacksonville 198
Houston 194
Beijing 189
Wilmington 171
Dearborn 147
Seattle 129
Cambridge 91
Santa Clara 88
Los Angeles 78
Nanjing 74
Shanghai 72
New York 66
Helsinki 62
Hefei 56
Boston 54
The Dalles 52
Munich 42
Seoul 36
Buffalo 34
Dong Ket 32
Nanchang 28
Spin 28
Guangzhou 27
Toronto 27
São Paulo 25
Hebei 24
Shenyang 24
Ho Chi Minh City 22
Redwood City 20
San Diego 20
Sestu 20
Redondo Beach 19
Brussels 18
Mountain View 18
Changsha 17
Chicago 17
Tempio Pausania 17
Tianjin 17
Montreal 16
Zhengzhou 16
Brooklyn 15
Milan 15
Orange 15
Tokyo 15
Hong Kong 14
Jiaxing 14
Atlanta 13
Frankfurt am Main 13
Turku 13
Warsaw 12
Hanoi 10
Ningbo 10
Nuremberg 10
Phoenix 10
Renton 10
Auburn Hills 9
London 9
Manchester 9
San Mateo 9
Amsterdam 8
Düsseldorf 8
Jinan 8
Rome 8
Stockholm 8
Verona 8
Chennai 7
Denver 7
Fuzhou 7
Johannesburg 7
Norwalk 7
Pune 7
San Francisco 7
Washington 7
Brasília 6
Ottawa 6
Rio de Janeiro 6
Sassari 6
Vienna 6
Belo Horizonte 5
Campinas 5
Dolianova 5
Hangzhou 5
Kunming 5
Mexico City 5
Orem 5
Suni 5
Sìnnai 5
Taizhou 5
Amman 4
Totale 141.076
Nome #
Leukocyte telomere length positively correlates with duration of lithium treatment in bipolar disorder patients 4.315
Count of “dark telomere” on the track of a biomarker for lithium treatment in bipolar disorder 4.226
Assessing RET/PTC in thyroid nodule fine-needle aspirates: the FISH point of view 4.004
Optimizing detection of RET and PPARg rearrangements in thyroid neoplastic cells using a home-brew tetracolor probe 3.838
Molecular and cytogenetic characterization of stem-like cells in human papillary thyroid carcinoma B-CPAP cell line 3.791
A multidisciplinary approach to mental illness: Do inflammation, telomere length and microbiota form a loop? A protocol for a cross-sectional study on the complex relationship between inflammation, telomere length, gut microbiota and psychiatric disorders 3.469
Thyrospheres from B-CPAP cell line with BRAF and TERT promoter mutations have different functional and molecular features than parental cells 3.377
Crosstalk between Metabolic Alterations and Altered Redox Balance in PTC-Derived Cell Lines 3.364
Deep fibrous histiocytoma with a clonal karyotypic alteration: molecular cytogenetic characterization of a t(16;17)(p13.3;q21.3). 3.260
Tetra-color break-apart probe to simultaneously locate RET and PPARg gene breakage in single thyroid cancer cells. 3.253
null 3.100
Differences in telomere length between patients with bipolar disorder and controls are influenced by lithium treatment 3.100
Assessing RET gene breakage in thyroid fine needle aspiration by fish: advantages and limits 3.077
Simultaneous occurrence of PAX8-PPARg and RET-PTC3 rearrangements in a follicular variant of papillary thyroid carcinoma. 3.071
Genetic heterogeneity of HER2 amplification and telomere shortening in papillary thyroid carcinoma 3.005
Telomere abnormalities and chromosome fragility in patients affected by familial papillary thyroid cancer. 2.946
Telomere attrition and inflammatory load in severe psychiatric disorders and in response to psychotropic medications 2.831
RET/PTC rearrangements in hashimoto’s thyroiditis nodules: contribution to an ongoing debate. 2.783
Characterizing the three-dimensional organization of telomeres in papillary thyroid carcinoma cells 2.776
null 2.686
Centrosome aberrations and spindle defects in thyroid carcinoma cells harboring specific oncogene activation 2.645
Trisomy 17 as a marker for a subset of noninvasive thyroid nodules with focal features of papillary carcinoma: cytogenetic and molecular analysis of 62 cases and correlation with histological findings 2.588
Thyroid autoimmunity and thyroid cancer: pathological and molecular study in a longitudinal series of unselected nodules. 2.494
Telomeric fusions and chromosome instability in familial papillary thyroid cancer patients 2.300
RET/PTC rearrangements in Hashimoto’s thyroiditis nodules 2.271
Autoimmunita’ tiroidea e carcinoma della tiroide: studio prospettico citologico, molecolare e istologico. 2.268
Centrosomal and mitotic abnormalities in cell lines derived from papillary thyroid cancer harboring specific gene alterations 2.267
RET/PTC rearragements in Hashimoto’s thyroiditis nodules. 2.264
RET/PTC rearrangement in Hashimoto’s thyroiditis nodules: contribution to an ongoing debate. 2.259
Riarrangiamenti RET/PTC in noduli insorti in tiroidite d’Hashimoto 2.179
RET/PTC rearrangements in unselected nodules from patients with Hashimoto’s thyroiditis 2.176
Fluorescence in situ hybridization patterns in newly diagnosed superficial bladder lesions and corresponding bladder washings 2.147
Familial papillary thyroid cancer patients display an elevated chromosome fragility characterized by telomeric association and telomere loss 2.109
Molecular characterization of a t (16;17) (p13.3;q21.3) translocation in a deep fibrous histiocytoma 1.977
16p13.3 and 17p21.3 chromosome breakpoints: are they randomly or non randomly affected in Deep Fibrous Histiocytoma? 1.886
Would a morphomolecular approach help in defining pseudosarcomatous myofibroblastic proliferations? A study of a heart polypoid lesion 1.799
A subgroup of thyroid lesions with PTC-FV features is characterized by trisomy 17 and lack of RET disruption, PAX8/PPARgamma1 fusion and BRAF mutations 1.798
A subgroup of thyroid lesions with PTC-FV features is characterized by trisomy 17 and lack of RET disruprion, PAX8/PPARgamma1 fusion and BRAF mutations. 1.744
Design of a specific DNA probe cocktail for targeting by FISH RET/PTC and PAX8/PPARg rearrangements in thyroid tumor cells 1.724
null 1.717
Polisomies and lack of ALK rearrangement in pseudosarcomatus myofibroblastic proliferation of the heart. 1.674
Molecular cytogenetics, a value added in the definition of myofibroblastic proliferation. 1.671
Identificazione e uso di sonde molecolari per una migliore caratterizzazione pre-chirurgica dei noduli tiroidei 1.561
Design of a specific DNA probe cocktail for targeting by FISH RET/PTC and PAX8/PPARG rearrangenments in thyroid tumor cell 1.531
Istiocitoma fibroso benigno profondo: un’altra lesione dei tessuti molli con anomalie cariotipiche? 1.528
Identificazione e uso di sonde molecolari per una migliore caratterizzazione pre-chirurgica del noduli tiroidei. 1.464
Numerical chromosome changes in thyroid cells from fine needle aspiration biopsy (FNAB). 1.429
FISH e FICTION su 108 agoaspirati tiroidei: risultati di uno studio preliminare 1.312
I-FISH in tumori superficiali della vescica: studio comparativo in lesioni primarie e concomitante lavaggio vescicale 1.282
Instabilità genomica nell’epitelio vescicale di soggetti forti fumatori:risultati di uno studio preliminare 1.255
Aneuploidy in oncocytic lesions of the thyroid gland: diffuse accumulation of mitochondria within the cell is associated with trisomy 7 and progressive numerical chromosomal alterations 1.183
A papillary thyroid tumour of the follicular variant harbouring RET/PTC and PAX8/PPARg gene fusion in different clones 1.179
Comprehensive conventional and molecular cytogenetic charaterization of B-CPAP, a human papillary thyroid carcinoma-derived cell line 1.110
Trisomia e assenza di fusione genica PAX8-PPARg1 in lesioni tiroidee benigne che sviluppano caratteristiche citologiche di carcinoma papillare/variante follicolare 1.080
Correlazione genotipo-morfotipo: attivazione di oncogeni diversi in cloni differenti in un tumore maligno differenziato della tiroide 1.064
null 1.045
Conventional and molecular cytogenetic characterization of the B-CPAP cell-line, derived from a papillary thyroid tumor with oncocytic features 883
Three-dimensional telomere profiles in papillary thyroid cancer variants: a pilot study 859
Anomalie cromosomiche in noduli tiroidei di pazienti con tiroidite di Hashimoto: esiste una relazione tra tipo di anomalia e tiroidite? 848
Vitamin c cytotoxicity and its effects in redox homeostasis and energetic metabolism in papillary thyroid carcinoma cell lines 823
Utilizzazione di materiale d'archivo per I-FISH: messa a punto di un protocollo unico su campioni di diversa provenienza 760
Distinct patterns of chromosomal and genomic instability characterize mouse models of malignant melanoma. 745
Tumori oncocitici della tiroide: relazione tra accumulo di mitocondri e aneuploidie in tumori follicolari e papillari 743
null 737
Genetic alterations distinguishing molecular subtypes of papillary thyroid tumors may influence the behaviour of corresponding stem-like cancer cells 710
May HER2 amplification be a molecular marker for a subgroup of familial papillary thyroid cancer? 701
Leukocyte telomere length in women with multiple sclerosis: Comparison with healthy women during pregnancy and puerperium 679
Does Hürtle cell carcinoma (but not Hürtle cell papillary carcinoma) aquire numerical chromosome changes 597
null 587
Riarrangiamenti RET/PTC in noduli insorti in tiroidite d’Hashimoto 545
null 531
null 529
Glutamine Starvation Affects Cell Cycle, Oxidative Homeostasis and Metabolism in Colorectal Cancer Cells 520
Trisomia 17 in noduli tiroidei: possibile predisposizione allo sviluppo di carcinomi papillari? 414
Molecular cytogenetics, a value added in the definition of myofibroblastic proliferations 402
A Pilot Interaction Analysis of Gut Microbiota and Peripheral Markers of Aging in Severe Psychiatric Disorders: A Role for Lachnoclostridium? 362
Citogenetica e citologia urinaria nelle neoplasie uroteliali: risultati preliminari di uno studio in tumori superficiali in prima manifestazione 278
Numerical chromosome changes in thyroid cells from FNAB 248
Combined cytogenetic and array-based comparative genomic hybridization of the B-CPAP human papillary thyroid carcinoma derived cell line 173
Do oncocytic cell in thyroid lesions preferntially become aneuploid? 164
Three-dimensional nuclear architecture distinguishes thyroid cancer histotypes. 103
Totale 144.193
Categoria #
all - tutte 169.977
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 169.977


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202117.747 0 0 0 0 0 4.705 2.821 2.409 1.333 2.465 2.297 1.717
2021/20227.923 1.205 567 620 739 723 550 528 380 688 624 618 681
2022/202310.392 847 1.400 1.309 961 730 831 565 668 842 761 1.022 456
2023/202410.751 562 540 449 525 944 1.689 1.641 918 603 693 1.005 1.182
2024/202515.054 3.080 4.029 2.068 1.906 910 1.054 1.189 91 204 169 160 194
2025/20262.231 374 245 521 363 394 334 0 0 0 0 0 0
Totale 144.193